Eric Goedken resumes & CV records
Resumes
Eric R Goedken, Age 52105 Hillcroft Ave, Worcester, MA 01606
Eric Goedken Phones & Addresses
105 Hillcroft Ave, Worcester, MA 01606 (508) 853-1608
1621 Blake St, Berkeley, CA 94703
Madison, WI
Osseo, WI
Social networks
Eric R Goedken
Linkedin
Mentions for Eric R Goedken
Publications & IP owners
Wikipedia
Null Device
After the amicable departures of Annis and Lawrence, Dr. Eric Goedken joined as a full-time lyricist and producer. Other more recent band contributors are guitarist Dan Clark ...
Us Patents
Novel Tricyclic Compounds
US Patent:
2011019, Aug 4, 2011
Filed:
Dec 1, 2010
Appl. No.:
12/958291
Inventors:
Neil Wishart - Jefferson MA, US
Maria A. Argiriadi - Wayland MA, US
David J. Calderwood - Framingham MA, US
Anna M. Ericsson - Shrewsbury MA, US
Bryan R. Fiamengo - Worcester MA, US
Kristine E. Frank - Worcester MA, US
Michael Friedman - Newton MA, US
Dawn M. George - Charlton MA, US
Eric R. Goedken - Worcester MA, US
Nathan S. Josephsohn - Boston MA, US
Biqin C. Li - Northborough MA, US
Michael J. Morytko - Framingham MA, US
Kent D. Stewart - Gurnee IL, US
Jeffrey W. Voss - Holden MA, US
Grier A. Wallace - Sterling MA, US
Lu Wang - Northborough MA, US
Kevin R. Woller - Anitoch IL, US
Eric C. Breinlinger - Charlton MA, US
Kelly D. Mullen - Charlton MA, US
Gagandeep Somal - Framingham MA, US
Maria A. Argiriadi - Wayland MA, US
David J. Calderwood - Framingham MA, US
Anna M. Ericsson - Shrewsbury MA, US
Bryan R. Fiamengo - Worcester MA, US
Kristine E. Frank - Worcester MA, US
Michael Friedman - Newton MA, US
Dawn M. George - Charlton MA, US
Eric R. Goedken - Worcester MA, US
Nathan S. Josephsohn - Boston MA, US
Biqin C. Li - Northborough MA, US
Michael J. Morytko - Framingham MA, US
Kent D. Stewart - Gurnee IL, US
Jeffrey W. Voss - Holden MA, US
Grier A. Wallace - Sterling MA, US
Lu Wang - Northborough MA, US
Kevin R. Woller - Anitoch IL, US
Eric C. Breinlinger - Charlton MA, US
Kelly D. Mullen - Charlton MA, US
Gagandeep Somal - Framingham MA, US
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C07D 413/14
C07D 471/14
C07D 487/14
C07F 9/06
C07D 471/14
C07D 487/14
C07F 9/06
US Classification:
544115, 546 82, 544346, 546 23, 544337, 544295
Abstract:
The invention provides a compound of Formula (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih), (Ii), (Ij), (Ik), or (Il) as defined herein, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Novel Tricyclic Compounds
US Patent:
2011031, Dec 22, 2011
Filed:
Dec 1, 2010
Appl. No.:
12/958115
Inventors:
Neil WISHART - Jefferson MA, US
Maria A. ARGIRIADI - Wayland MA, US
David J. CALDERWOOD - Framingham MA, US
Anna M. ERICSSON - Shrewsbury MA, US
Bryan R. FIAMENGO - Worcester MA, US
Kristine E. FRANK - Worcester MA, US
Michael FRIEDMAN - Newton MA, US
Dawn M. GEORGE - Charlton MA, US
Eric R. GOEDKEN - Worcester MA, US
Nathan S. JOSEPHSOHN - Boston MA, US
Biqin C. LI - Southborough MA, US
Michael J. MORYTKO - Framingham MA, US
Kent D. STEWART - Gurnee IL, US
Jeffrey W. VOSS - Holden MA, US
Grier A. WALLACE - Sterling MA, US
Lu WANG - Northborough MA, US
Kevin R. WOLLER - Anitoch IL, US
Maria A. ARGIRIADI - Wayland MA, US
David J. CALDERWOOD - Framingham MA, US
Anna M. ERICSSON - Shrewsbury MA, US
Bryan R. FIAMENGO - Worcester MA, US
Kristine E. FRANK - Worcester MA, US
Michael FRIEDMAN - Newton MA, US
Dawn M. GEORGE - Charlton MA, US
Eric R. GOEDKEN - Worcester MA, US
Nathan S. JOSEPHSOHN - Boston MA, US
Biqin C. LI - Southborough MA, US
Michael J. MORYTKO - Framingham MA, US
Kent D. STEWART - Gurnee IL, US
Jeffrey W. VOSS - Holden MA, US
Grier A. WALLACE - Sterling MA, US
Lu WANG - Northborough MA, US
Kevin R. WOLLER - Anitoch IL, US
Assignee:
ABBOTT LABORATORIES - Abbott Park IL
International Classification:
A61K 31/4985
C07D 471/14
A61K 31/437
A61K 39/395
A61P 25/00
A61K 38/21
A61K 38/18
A61K 31/573
A61P 35/00
A61P 37/06
C07D 487/14
A61K 38/20
C07D 471/14
A61K 31/437
A61K 39/395
A61P 25/00
A61K 38/21
A61K 38/18
A61K 31/573
A61P 35/00
A61P 37/06
C07D 487/14
A61K 38/20
US Classification:
424 852, 544346, 546 82, 514250, 514293, 51421021, 4241581, 424 854, 424 851, 514 91, 514 82, 4241421, 514171, 424 856, 424 857, 424 855
Abstract:
The invention provides compounds of Formula (I) and Formula (II)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Novel Tricyclic Compounds
US Patent:
2013021, Aug 22, 2013
Filed:
Feb 7, 2013
Appl. No.:
13/761501
Inventors:
Neil Wishart - Jefferson MA, US
Maria A. Argiriadi - Wayland MA, US
David J. Calderwood - Framingham MA, US
Anna M. Ericsson - Shrewsbury MA, US
Bryan A. Fiamengo - Worcester MA, US
Kristine E. Frank - Worcester MA, US
Michael Friedman - Brookline MA, US
Dawn M. George - Charlton MA, US
Eric R. Goedken - Worcester MA, US
Nathan S. Josephsohn - Boston MA, US
Biqin C. Li - Northborough MA, US
Michael J. Morytko - Framingham MA, US
Kent D. Stewart - Gurnee IL, US
Jeffrey W. Voss - Holden MA, US
Grier A. Wallace - Sterling MA, US
Lu Wang - Northborough MA, US
Kevin R. Woller - Antioch IL, US
Maria A. Argiriadi - Wayland MA, US
David J. Calderwood - Framingham MA, US
Anna M. Ericsson - Shrewsbury MA, US
Bryan A. Fiamengo - Worcester MA, US
Kristine E. Frank - Worcester MA, US
Michael Friedman - Brookline MA, US
Dawn M. George - Charlton MA, US
Eric R. Goedken - Worcester MA, US
Nathan S. Josephsohn - Boston MA, US
Biqin C. Li - Northborough MA, US
Michael J. Morytko - Framingham MA, US
Kent D. Stewart - Gurnee IL, US
Jeffrey W. Voss - Holden MA, US
Grier A. Wallace - Sterling MA, US
Lu Wang - Northborough MA, US
Kevin R. Woller - Antioch IL, US
International Classification:
C07D 487/14
A61K 45/06
A61K 31/437
A61K 31/4985
C07D 471/14
A61K 45/06
A61K 31/437
A61K 31/4985
C07D 471/14
US Classification:
424 852, 544346, 514250, 546 82, 514293, 51421021, 4241581, 424 854
Abstract:
The invention provides compounds of Formula (I) and Formula (II)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Novel Tricyclic Compounds
US Patent:
2009031, Dec 17, 2009
Filed:
Jun 9, 2009
Appl. No.:
12/481028
Inventors:
Neil Wishart - Jefferson MA, US
Maria A. Argiriadi - Wayland MA, US
David J. Calderwood - Framingham MA, US
Anna M. Ericsson - Shrewsbury MA, US
Bryan A. Fiamengo - Worcester MA, US
Kristine E. Frank - Worcester MA, US
Michael Friedman - Newton MA, US
Dawn M. George - Charlton MA, US
Eric R. Goedken - Worcester MA, US
Nathan S. Josephsohn - Boston MA, US
Biqin C. Li - Northborough MA, US
Michael J. Morytko - Framingham MA, US
Kent D. Stewart - Gurnee IL, US
Jeffrey W. Voss - Holden MA, US
Grier A. Wallace - Sterling MA, US
Lu Wang - Northborough MA, US
Kevin R. Woller - Anitoch IL, US
Maria A. Argiriadi - Wayland MA, US
David J. Calderwood - Framingham MA, US
Anna M. Ericsson - Shrewsbury MA, US
Bryan A. Fiamengo - Worcester MA, US
Kristine E. Frank - Worcester MA, US
Michael Friedman - Newton MA, US
Dawn M. George - Charlton MA, US
Eric R. Goedken - Worcester MA, US
Nathan S. Josephsohn - Boston MA, US
Biqin C. Li - Northborough MA, US
Michael J. Morytko - Framingham MA, US
Kent D. Stewart - Gurnee IL, US
Jeffrey W. Voss - Holden MA, US
Grier A. Wallace - Sterling MA, US
Lu Wang - Northborough MA, US
Kevin R. Woller - Anitoch IL, US
Assignee:
ABBOTT LABORATORIES - Abbott Park IL
International Classification:
A61K 31/4985
C07D 487/14
C07D 487/14
US Classification:
514250, 544346
Abstract:
The invention provides a compound of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Novel Tricyclic Compounds
US Patent:
2023008, Mar 16, 2023
Filed:
Jan 14, 2022
Appl. No.:
17/575731
Inventors:
- North Chicago IL, US
Maria A. ARGIRIADI - Wayland MA, US
David J. CALDERWOOD - Framingham MA, US
Anna M. Ericsson - Shrewsbury MA, US
Bryan A. FIAMENGO - Worcester MA, US
Kristine E. FRANK - Grayslake IL, US
Michael M. FRIEDMAN - Brookline MA, US
Dawn M. GEORGE - Charlton MA, US
Eric R. GOEDKEN - Worcester MA, US
Nathan S. JOSEPHSOHN - Cambridge MA, US
Biqin C. LI - Southborough MA, US
Michael J. MORYTKO - Framingham MA, US
Kent D. STEWART - Gurnee IL, US
Jeffrey W. VOSS - Holden MA, US
Grier A. WALLACE - Sterling MA, US
Lu WANG - Northborough MA, US
Kevin R. WOLLER - Antioch IL, US
Maria A. ARGIRIADI - Wayland MA, US
David J. CALDERWOOD - Framingham MA, US
Anna M. Ericsson - Shrewsbury MA, US
Bryan A. FIAMENGO - Worcester MA, US
Kristine E. FRANK - Grayslake IL, US
Michael M. FRIEDMAN - Brookline MA, US
Dawn M. GEORGE - Charlton MA, US
Eric R. GOEDKEN - Worcester MA, US
Nathan S. JOSEPHSOHN - Cambridge MA, US
Biqin C. LI - Southborough MA, US
Michael J. MORYTKO - Framingham MA, US
Kent D. STEWART - Gurnee IL, US
Jeffrey W. VOSS - Holden MA, US
Grier A. WALLACE - Sterling MA, US
Lu WANG - Northborough MA, US
Kevin R. WOLLER - Antioch IL, US
International Classification:
C07D 487/14
C07D 498/14
C07D 513/14
C07D 498/14
C07D 513/14
Abstract:
The invention provides a compound of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Novel Tricyclic Compounds
US Patent:
2021006, Mar 4, 2021
Filed:
Jun 13, 2019
Appl. No.:
16/440442
Inventors:
- North Chicago IL, US
Maria A. ARGIRIADI - Southborough MA, US
David J. CALDERWOOD - Framingham MA, US
Anna M. ERICSSON - Shrewsbury MA, US
Bryan A. FIAMENGO - Anaheim CA, US
Kristine E. FRANK - Grayslake IL, US
Michael M. FRIEDMAN - Kennebunkport ME, US
Dawn M. GEORGE - Lancaster MA, US
Eric R. GOEDKEN - Worcester MA, US
Nathan S. JOSEPHSOHN - Cambridge MA, US
Biqin C. LI - Naples FL, US
Michael J. MORYTKO - Westborough MA, US
Kent D. STEWART - Charlotte NC, US
Jeffrey W. VOSS - Holden MA, US
Grier A. WALLACE - Sterling MA, US
Lu WANG - Northborough MA, US
Kevin R. WOLLER - Antioch IL, US
Maria A. ARGIRIADI - Southborough MA, US
David J. CALDERWOOD - Framingham MA, US
Anna M. ERICSSON - Shrewsbury MA, US
Bryan A. FIAMENGO - Anaheim CA, US
Kristine E. FRANK - Grayslake IL, US
Michael M. FRIEDMAN - Kennebunkport ME, US
Dawn M. GEORGE - Lancaster MA, US
Eric R. GOEDKEN - Worcester MA, US
Nathan S. JOSEPHSOHN - Cambridge MA, US
Biqin C. LI - Naples FL, US
Michael J. MORYTKO - Westborough MA, US
Kent D. STEWART - Charlotte NC, US
Jeffrey W. VOSS - Holden MA, US
Grier A. WALLACE - Sterling MA, US
Lu WANG - Northborough MA, US
Kevin R. WOLLER - Antioch IL, US
Assignee:
AbbVie Inc. - North Chicago IL
International Classification:
C07D 487/14
A61K 45/06
A61K 31/4985
A61K 31/437
C07D 471/14
C07D 498/14
C07D 513/14
A61K 45/06
A61K 31/4985
A61K 31/437
C07D 471/14
C07D 498/14
C07D 513/14
Abstract:
The invention provides compounds of Formula (I) and Formula (II)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Novel Tricyclic Compounds
US Patent:
2018029, Oct 11, 2018
Filed:
Nov 7, 2017
Appl. No.:
15/806104
Inventors:
- North Chicago IL, US
Maria A. Argiriadi - Wayland MA, US
David J. Calderwood - Framingham MA, US
Anna M. Ericsson - Shrewsbury MA, US
Bryan R. Fiamengo - Worcester MA, US
Kristine E. Frank - Grayslake IL, US
Michael M. Friedman - Brookline MA, US
Dawn M. George - Charlton MA, US
Eric R. Goedken - Worcester MA, US
Nathan S. Josephsohn - Cambridge MA, US
Biqin C. Li - Southborough MA, US
Michael J. Morytko - Framingham MA, US
Kent D. Stewart - Gurnee IL, US
Jeffrey W. Voss - Holden MA, US
Grier A. Wallace - Sterling MA, US
Lu Wang - Northborough MA, US
Kevin R. Woller - Antioch IL, US
Maria A. Argiriadi - Wayland MA, US
David J. Calderwood - Framingham MA, US
Anna M. Ericsson - Shrewsbury MA, US
Bryan R. Fiamengo - Worcester MA, US
Kristine E. Frank - Grayslake IL, US
Michael M. Friedman - Brookline MA, US
Dawn M. George - Charlton MA, US
Eric R. Goedken - Worcester MA, US
Nathan S. Josephsohn - Cambridge MA, US
Biqin C. Li - Southborough MA, US
Michael J. Morytko - Framingham MA, US
Kent D. Stewart - Gurnee IL, US
Jeffrey W. Voss - Holden MA, US
Grier A. Wallace - Sterling MA, US
Lu Wang - Northborough MA, US
Kevin R. Woller - Antioch IL, US
Assignee:
AbbVie Inc. - North Chicago IL
International Classification:
C07D 487/14
C07D 513/14
C07D 498/14
C07D 513/14
C07D 498/14
Abstract:
The invention provides a compound of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Novel Tricyclic Compounds
US Patent:
2016032, Nov 10, 2016
Filed:
May 12, 2016
Appl. No.:
15/152823
Inventors:
- North Chicago IL, US
Maria A. Argiriadi - Wayland MA, US
David J. Calderwood - Framingham MA, US
Anna M. Ericsson - Shrewsbury MA, US
Bryan R. Fiamengo - Worcester MA, US
Kristine E. Frank - Grayslake IL, US
Michael M. Friedman - Brookline MA, US
Dawn M. George - Charlton MA, US
Eric R. Goedken - Worcester MA, US
Nathan S. Josephsohn - Cambridge MA, US
Biqin C. Li - Southborough MA, US
Michael J. Morytko - Framingham MA, US
Kent D. Stewart - Gurnee IL, US
Jeffrey W. Voss - Holden MA, US
Grier A. Wallace - Sterling MA, US
Lu Wang - Northborough MA, US
Kevin R. Woller - Antioch IL, US
Maria A. Argiriadi - Wayland MA, US
David J. Calderwood - Framingham MA, US
Anna M. Ericsson - Shrewsbury MA, US
Bryan R. Fiamengo - Worcester MA, US
Kristine E. Frank - Grayslake IL, US
Michael M. Friedman - Brookline MA, US
Dawn M. George - Charlton MA, US
Eric R. Goedken - Worcester MA, US
Nathan S. Josephsohn - Cambridge MA, US
Biqin C. Li - Southborough MA, US
Michael J. Morytko - Framingham MA, US
Kent D. Stewart - Gurnee IL, US
Jeffrey W. Voss - Holden MA, US
Grier A. Wallace - Sterling MA, US
Lu Wang - Northborough MA, US
Kevin R. Woller - Antioch IL, US
Assignee:
AbbVie Inc. - North Chicago IL
International Classification:
C07D 487/14
Abstract:
The invention provides a compound of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.